Skip navigation
MedlinePlus Trusted Health Information for You U.S. National Library of MedicineNational Institutes of Health
Contact Us FAQs Site Map About MedlinePlus
español Home Health Topics Drugs & Supplements Medical Encyclopedia Dictionary News Directories Other Resources

 

Medical Encyclopedia

Other encyclopedia topics:  A-Ag  Ah-Ap  Aq-Az  B-Bk  Bl-Bz  C-Cg  Ch-Co  Cp-Cz  D-Di  Dj-Dz  E-Ep  Eq-Ez  F  G  H-Hf  Hg-Hz  I-In  Io-Iz  J  K  L-Ln  Lo-Lz  M-Mf  Mg-Mz  N  O  P-Pl  Pm-Pz  Q  R  S-Sh  Si-Sp  Sq-Sz  T-Tn  To-Tz  U  V  W  X  Y  Z  0-9 

Testicular cancer

Printer-friendly versionEmail this page to a friend
Contents of this page:

Illustrations

Male reproductive anatomy
Male reproductive anatomy
Male reproductive system
Male reproductive system

Alternative Names    Return to top

Cancer - testes; Germ cell tumor; Seminoma testicular cancer; Nonseminoma testicular cancer

Definition    Return to top

Testicular cancer is cancer that starts in the testicles, the male sex glands located next to the penis.

Causes    Return to top

The exact cause of testicular cancer is unknown. However, several factors seem to increase a man's risk for the condition. They include:

Other factors under investigation as possible causes include exposure to certain chemicals and HIV infection. A family history of testicular cancer may also increase risk.

There is no link between vasectomy and testicular cancer.

Testicular cancer accounts for only 1% of all cancers in men in the U.S., but is the most common form of cancer in men age 15 - 40. In rare cases, it may occur at a younger age.

White men are five times more likely to develop this type of cancer than African Americans. White men are twice as likely as Asian-American men to have testicular cancer.

There are two main types of testicular cancer: Seminomas and nonseminomas. These cancers grow from germ cells, the cells that make sperm.

Seminoma: This is a slow-growing form of testicular cancer usually found in men in their 30s and 40s. The cancer is usually just in the testes. However, it can spread to the lymph nodes.

Nonseminoma: This more common type of testicular cancer tends to grow more quickly than seminomas. Nonseminoma tumors are often made up of different cell types, and are identified according to the cells in which they start to grow. Nonseminoma testicular cancers include:

A stromal tumor is a rare type of testicular tumor. Such tumors are usually not cancerous. The two main types of stromal tumors are Leydig cell tumors and Sertoli cell tumors. Leydig cells release the hormone testosterone, and Sertoli cells are where sperm matures. Stromal tumors may be seen during childhood.

Symptoms    Return to top

Note: There may be no symptoms.

Exams and Tests    Return to top

A physical examination typically reveals a firm lump (mass). When the health care provider holds a flashlight up to the scrotum, the light does not pass through the mass.

Other tests include:

Tissue biopsy is usually done by removing the testicle with surgery and then examining the tissue.

Treatment    Return to top

Treatment depends on the:

Most patients can be cured.

Once cancer is found, the first step is to determine the type of cancer cell by examining it under a microscope. The cells can be seminoma or nonseminoma. If both seminoma and nonseminoma cells are found in a single tumor, the tumor is treated as a nonseminoma.

The next step is to determine how far the cancer has spread to other parts of the body. This is called "staging."

Three types of treatment can be used.

  1. Surgical treatment removes the testicle (orchiectomy) and associated lymph nodes (lymphadenectomy). This is usually performed in the case of both seminoma and nonseminomas.
  2. Radiation therapy using high-dose x-rays or other high-energy rays may be used after surgery to prevent the tumor from returning. Radiation therapy is usually only used for treating seminomas.
  3. Chemotherapy uses drugs such as cisplatin, bleomycin, and etoposide to kill cancer cells. This treatment has greatly improved survival for patients with both seminomas and nonseminomas.

Support Groups    Return to top

Joining a support group where members share common experiences and problems can often help the stress of illness. Your local branch of the American Cancer Society may have a support group.

Lance Armstrong, a famous cyclist, is a survivor of testicular cancer. His web site -- www.laf.org -- offers support and information for patients with testicular cancer.

The National Cancer Institute also offers such information. Visit their website at www.cancer.gov.

Outlook (Prognosis)    Return to top

Testicular cancer is one of the most treatable cancers.

The survival rate for men with early-stage seminoma (the least aggressive type of testicular cancer) is greater than 95%. The disease-free survival rate for Stage II and III cancers is slightly lower, depending on the size of the tumor and when treatment is begun.

Possible Complications    Return to top

Testicular cancer may spread to other parts of the body. The most common sites include the:

Complications of surgery can include:

If you are of childbearing age, ask your doctor about nerve-sparing surgery and methods to save your sperm for use at a later date.

When to Contact a Medical Professional    Return to top

Call your health care provider if you have symptoms of testicular cancer.

Prevention    Return to top

There is no known effective screening technique for testicular cancer. However, a testicular self-examination (TSE) performed on a monthly basis may help in detecting such cancer at an early stage, before it spreads. Finding it early is important to successful treatment and survival. Young men are often taught how to perform such exams shortly after puberty.

References    Return to top

U.S. Preventive Services Task Force (USPSTF). Screening for testicular cancer: recommendation statement. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2004 Feb. 2 p.

Update Date: 6/10/2008

Updated by: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; and James R. Mason, MD, Oncologist, Director, Blood and Marrow Transplantation Program and Stem Cell Processing Lab, Scripps Clinic, Torrey Pines, California. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

A.D.A.M. Logo

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2009, A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.